prof. dr. E. (Eelko) Hak
Full professor of Clinical Pharmacoepidemiology/Educational director Pharmacy-MPS
Methodology of (un)intentional drug/vaccine effect research with "real-world Big Data" (e.g. case-control, case-only, sibling designs, instrumental variable analysis, propensity score analysis, also in combination with cost-effectiveness research and in relation to Precision Medicine. Clinical epidemiology of (respiratory) infections, antibiotic treatment and vaccination. Implementation research of medication/vaccine strategies (adherence, persistence) in public health.
Additional activities: Honorary professor at department of Epidemiology, UMC Groningen. Director consultancy Epicoach V.O.F. (see www.epicoach.nl). Member as methodologist of the Medical Ethical Review Board Isala Hospital Zwolle. Member of the Dutch Health Council committee COVID-19. Member of the Dutch Health Council Vaccinations and Health Council Influenza vaccination (till 2019). Member as methodologist of the Medical Ethical Review Board BEBO, Assen (evaluates >60% of phase 1 clinical drug trials in NL). Programme director master Medical Pharmaceutical Sciences (MPS, Keuzegids 2017&2019: Top-rated program, see www.rug.nl\masters\MPS ). Co-chair GUIDE graduate school research group Real-world studies in Pharmaco-Epidemiology, -Genetics, -Economics & -Therapy (PEGET). Work Package leader clinical vaccine trial program FP7-project UNISEC (2013-2019). Member of the Faculty Council Faculty of Science and Engineering (till 2019). Educational Director of BSC and MSC Pharmacy and MSC MPS.
|Last modified:||04 January 2021 1.12 p.m.|